1E7-03
CAS No. 1565845-92-2
1E7-03 ( 1E703; 1E7 03; 1E7-03 )
Catalog No. M12234 CAS No. 1565845-92-2
1E7-03 is a small molecule targeting the RVxF interacting site on PP1, inhibits HIV-1, Ebolavirus (EBOV), and Venezuelan equine encephalitis virus (VEEV, EC50=0.6 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
|
50MG | 1782 | Get Quote |
|
100MG | 2250 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name1E7-03
-
NoteResearch use only, not for human use.
-
Brief Description1E7-03 is a small molecule targeting the RVxF interacting site on PP1, inhibits HIV-1, Ebolavirus (EBOV), and Venezuelan equine encephalitis virus (VEEV, EC50=0.6 uM).
-
Description1E7-03 is a small molecule targeting the RVxF interacting site on PP1, inhibits HIV-1, Ebolavirus (EBOV), and Venezuelan equine encephalitis virus (VEEV, EC50=0.6 uM); disrupts the interaction of Tat with PP1, inhibits HIV-1 transcription with IC50 of 2 uM, with no cytotoxicity and displays a plasma half-life greater than 8 h in mice; inhibits EBOV transcription and strongly induces VP30 phosphorylation in the N-terminal Ser residues 29-46.
-
Synonyms1E703; 1E7 03; 1E7-03
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1565845-92-2
-
Formula Weight503.56
-
Molecular FormulaC28H29N3O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=C(CC/C2=C\C3=CC=C(OC)C(OC)=C3)C2=NC4=CC=CC=C14)OC(C)C(NC(NCC)=O)=O
-
Chemical Name1-(3-ethylureido)-1-oxopropan-2-yl (Z)-3-(3,4-dimethoxybenzylidene)-2,3-dihydro-1H-cyclopenta[b]quinoline-9-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Carey BD, et al. J Virol. 2018 May 16. pii: JVI.02068-17.
2. Ilinykh PA, et al. J Biol Chem. 2014 Aug 15;289(33):22723-38.
3. Ammosova T, et al. Br J Pharmacol. 2014 Nov;171(22):5059-75.
4. Lin X, et al. Oncotarget. 2017 Aug 7;8(44):76749-76769.
2. Ilinykh PA, et al. J Biol Chem. 2014 Aug 15;289(33):22723-38.
3. Ammosova T, et al. Br J Pharmacol. 2014 Nov;171(22):5059-75.
4. Lin X, et al. Oncotarget. 2017 Aug 7;8(44):76749-76769.
molnova catalog
related products
-
Apelin-36 (rat, mous...
Endogenous APJ receptor agonist that is secreted by adipocytes. Binds with high affinity to APJ receptors (IC50 = 5.4 nM) and potently inhibits cAMP production in vitro (EC50 = 0.52 nM). Involved in regulation of cardiovascular function, fluid homeostasis and feeding. Blocks entry of some HIV-1 and HIV-2 strains into NP-2/CD4 cells expressing APJ.
-
Nef-IN-B9
Nef-IN-B9 (Nef inhibitor B9) is a small molecule that blocks Nef-dependent Hck activity with IC50 of 2.8 uM.
-
Lopinavir
Lopinavir (also known as ABT-378) is a highly potent inhibitor of human immunodeficiency virus (HIV) protease that potently inhibits wild-type and mutant HIV protease.